XCUR: Exicure, Inc. Stock

by  •  • Comments Off on XCUR: Exicure, Inc. Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 55.91
Enterprise Value ($M) 43.40
Book Value ($M) 6.77
Book Value / Share 1.07
Price / Book 8.26
NCAV ($M) 5.39
NCAV / Share 0.85
Price / NCAV 10.38

Profitability (mra)
Return on Invested Capital (ROIC) -0.76
Return on Assets (ROA) n/a
Return on Equity (ROE) n/a

Liquidity (mrq)
Quick Ratio 4.45
Current Ratio 4.45

Balance Sheet (mrq) ($M)
Current Assets 13.67
Assets 15.06
Liabilities 8.28
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 0.50
Operating Income -4.95
Net Income -9.70
Earnings Per Share Basic And Diluted n/a

Cash Flow Statement (mra) ($M)
Cash From Operations -2.91
Cash from Investing 0.00
Cash from Financing 13.40

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)		 Change
(%)
03-26 13D/A HiTron Systems Inc. 52.80 669.23
12-23 13G Sangsangin Investment & Securities Co., Ltd. 14.30
09-16 13D/A CBI USA, Inc. 39.10 -72.25

Top 13F Investors Shares
(1000)		 Change
(%)		 Value
($1000)		 Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2025-03-18 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K
2024-11-14 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q
2024-08-13 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q
2024-06-17 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q
2024-06-06 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K
2024-06-06 10-Q/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q/A Amendment No. 2
2024-06-06 10-Q/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q/A Amendment No. 2
2024-05-16 10-Q/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q/A Amendment No. 1
2024-05-16 10-Q/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q/A Amendment No. 1
2024-05-16 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2025-04-17 10,321 50,086 20.61
2025-04-16 54,444 161,683 33.67
2025-04-15 39,202 103,211 37.98
2025-04-14 901 3,998 22.54

(click for more detail)

Similar Companies
WHWK – Whitehawk Therapeutics, Inc. WINT – Windtree Therapeutics, Inc.
XBIO – Xenetic Biosciences, Inc. XFOR – X4 Pharmaceuticals, Inc.
ZURA – Zura Bio Limited


Financial data and stock pages provided by
Fintel.io